115
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Left ventricular diastolic function evaluated by the E/e’ ratio is impaired in patients with masked uncontrolled hypertension

, , , , &
Pages 538-544 | Received 21 Jul 2013, Accepted 09 Oct 2013, Published online: 03 Feb 2014

References

  • Hernandez del-Rey R, Armario P, Martin-Baranera M, et al. Cardiac damage in hypertensive patients with inverse white coat hypertension. Hospitalet study. Blood Press 2003;12:89–96
  • Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999;131:564–72
  • Bjorklund K, Lind L, Zethelius B, et al. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003;107:1297–302
  • Matsui Y, Eguchi K, Ishikawa J, et al. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement. Am J Hypertens 2007;20:385–91
  • Bobrie G, Clerson P, Menard J, et al. Masked hypertension: a systematic review. J Hypertens 2008;26:1715–25
  • Obara T, Ohkubo T, Kikuya M, et al. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study. Blood Press Monit 2005;10:311–16
  • Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291:1342–9
  • Obara T, Ohkubo T, Funahashi J, et al. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens 2005;23:1653–60
  • Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005;18:1422–8
  • Tomiyama M, Horio T, Yoshii M, et al. Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens 2006;19:880–6
  • Slama M, Susic D, Varagic J, Frohlich ED. Diastolic dysfunction in hypertension. Curr Opin Cardiol 2002;17:368–73
  • Kane GC, Karon BL, Mahoney DW, et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 2011;306:856–63
  • Chinnaiyan KM, Alexander D, Maddens M, McCullough PA. Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am Heart J 2007;153:189–200
  • Aljaroudi W, Alraies MC, Halley C, et al. Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation 2012;125:782–8
  • Achong N, Wahi S, Marwick TH. Evolution and outcome of diastolic dysfunction. Heart 2009;95:813–18
  • Zhang Y, Safar ME, Iaria P, et al. Prevalence and prognosis of left ventricular diastolic dysfunction in the elderly: the PROTEGER study. Am Heart J 2010;160:471–8
  • Schillaci G, Pasqualini L, Verdecchia P, et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 2002;39:2005–11
  • Sharp AS, Tapp RJ, Thom SA, et al. Tissue Doppler E/E′ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J 2010;31:747–52
  • Oe Y, Shimbo D, Ishikawa J, et al. Alterations in diastolic function in masked hypertension: findings from the masked hypertension study. Am J Hypertens 2013;26:808–15
  • Cohen DL, Townsend RR. Masked hypertension: an increasingly common but often unrecognized issue in hypertension management. J Clin Hypertens (Greenwich) 2010;12:522–3
  • Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183–97
  • National Cholesterol Education Program. Second Report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1333–445
  • Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol 2009;13:537–66
  • Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008;26:1505–26
  • Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–63
  • Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976;37:7–11
  • Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613–18
  • Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107–33
  • Masuyama T, Popp RL. Doppler evaluation of left ventricular filling in congestive heart failure. Eur Heart J 1997;18:1548–56
  • Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788–94
  • Marchesi C, Maresca AM, Solbiati F, et al. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function. Am J Hypertens 2007;20:1079–84
  • Ng CM, Yiu SF, Choi KL, et al. Prevalence and significance of white-coat hypertension and masked hypertension in type 2 diabetics. Hong Kong Med J 2008;14:437–43
  • Hoshide S, Ishikawa J, Eguchi K, et al. Masked nocturnal hypertension and target organ damage in hypertensives with well-controlled self-measured home blood pressure. Hypertens Res 2007;30:143–9
  • Grassi G, Seravalle G, Trevano FQ, et al. Neurogenic abnormalities in masked hypertension. Hypertension 2007;50:537–42
  • Long CS, Ordahl CP, Simpson PC. Alpha 1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells. J Clin Invest 1989;83:1078–82
  • Leite-Moreira AF. Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 2006;92:712–18
  • Muller-Brunotte R, Kahan T, Lopez B, et al. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). J Hypertens 2007;25:1958–66
  • Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002;105:1503–8
  • Solomon SD, Janardhanan R, Verma A, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007;369:2079–87
  • Mancia G, Parati G. The role of blood pressure variability in end-organ damage. J Hypertens Suppl 2003;21:S17–23
  • Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987;5:93–8
  • Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007;30:479–88
  • Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 2008;52:1–9
  • Alam M, Samad BA, Wardell J, et al. Acute effects of smoking on diastolic function in healthy participants: studies by conventional doppler echocardiography and doppler tissue imaging. J Am Soc Echocardiogr 2002;15:1232–7
  • Gembala MI, Ghanem F, Mann CA, Sorrell VL. Acute changes in left ventricular diastolic function: cigarette smoking versus nicotine gum. Clin Cardiol 2006;29:61–4
  • Yilmaz A, Yalta K, Turgut OO, et al. The effect of smoking on cardiac diastolic parameters including Vp, a more reliable and newer parameter. Cardiol J 2007;14:281–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.